Siegfried Janz

21PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 17, 2025
Molecular and immunological determinants of long-term survival in multiple myeloma.

Khanmi Kasomva, Kritika Yadav, Siegfried Janz

|Mar 05, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.

Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng

|Jan 19, 2024
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.

Fumou Sun, Yan Cheng, Visanu Wanchai

|Jul 06, 2022
FOXM1 regulates glycolysis and energy production in multiple myeloma.

Yan Cheng, Fumou Sun, Krista Thornton

|Feb 25, 2022
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study.

Jing Dong, Zhuping Garacci, Christopher Staffi Buradagunta

|Jan 28, 2022
Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.

Yijiang Shi, Fumou Sun, Yan Cheng

Pageof 4